Clinical InvestigationHomoarginine in Patients With Primary Hyperparathyroidism

Add time:08/17/2019    Source:sciencedirect.com

BackgroundLow levels of the amino acid homoarginine and parathyroid hormone (PTH) excess are both independently related to an increased risk of cardiovascular morbidity and mortality. Accumulating evidence points to a mutual interplay between homoarginine and PTH. The authors therefore aimed to investigate circulating homoarginine levels in patients with and without primary hyperparathyroidism (PHPT).

We also recommend Trading Suppliers and Manufacturers of D-HOMOARGININE (cas 110798-13-5). Pls Click Website Link as below: cas 110798-13-5 suppliers

Prev:Rearrangement of isoxazoline-5-spiro derivatives. Part 10. Regioselective nitrone cycloadditions to MethoxycarbonylMethylenecyclopropane (cas 110793-87-8): Synthesis of precursors of (±)-Lupinine, (±)-Epilupinine and (±)-Elaeokanine A☆
Next:Simultaneous determination of asymmetric and symmetric dimethylarginine, l-monomethylarginine, l-arginine, and l-homoarginine in biological samples using stable isotope dilution liquid chromatography tandem mass spectrometry)